The probability of middle cerebral artery MRA flow signal abnormality with quantified CT ischaemic change: Targets for future therapeutic studies

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 10, 2004, Pages 1426-1430

  Barber, P A ^a,b   Demchuk, A M ^b   Hill, M D ^a,b   Warwick Pexman, J H ^b   Hudon, M E ^a,b   Frayne, R ^a,b   Buchan, A M ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b Seaman Family MR Research Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN CIRCULATION; BRAIN ISCHEMIA; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; PREDICTION; PRIORITY JOURNAL; PROBABILITY; QUANTITATIVE DIAGNOSIS; SCORING SYSTEM; THREE DIMENSIONAL IMAGING;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 4644338837     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2003.029389     Document Type: Article

References (31)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
2. del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78-86.
3. The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA stroke trial. Stroke 1997;28:2119.
4. Hacke W, Kaste M, Fieschi C, et al, for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-25.
5. Hacke W, Kaste M, Fieschi C, et al. Randomised double blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998;352:1245-51.
6. Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator for ischemic stroke 3-5 hours after symptom onset. The ATLANTIS Study: a randomised controlled trial. JAMA 1999;282:2019-26.
7. Furlan A, Higashida R, Wechsler L, et al, for the PROACT investigators. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II Study: a randomised controlled trial. JAMA 1999;282:2003-11.
8. Barber PA, Demchuk AM, Zhang J, et al. Hyperacute stroke: the validity and reliability of a novel quantitative CT score in predicting outcome prior to thrombolytic therapy. Lancet 2000;355:1670-4.
9. Pexman JHW, Barber PA, Hill MD, et al. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol 2001;22:1534-42.
10. Leys D, Pruvo JP, Godefroy O, et al. Prevalence and significance of hyperdense middle cerebral artery in acute stroke. Stroke 1992;23:317-24.
11. Barber PA, Demchuk AM, Zhang J, et al. The hyperdense sylvian fissure MCA "dot" sign". A CT marker of acute cerebral ischemia. Stroke 2001;32:84-8.
12. Bastianello S, Pierallini A, Colonnese C, et al. Hyperdense middle cerebral artery CT sign. Comparison with angiography in the acute phase of ischemic supratentorial infarction. Neuroradiology 1991;33:207.
13. Leary MC, Saver JL, Kidwell CS, et al. Validation of the CT MCA dot sign: an angiographic correlation study (abstract). Stroke 2002;33:342.
14. Barber PA, Demchuk AM, Hill MD, et al. A comparison of CT versus MR imaging in acute stroke using ASPECTS: will the "new" replace the "old" as the preferred imaging modality? (abstract). Stroke 2001;32:325.
15. Frayne R, Goodyear BG, Dickhoff P, et al. Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging. Invest Radiol 2003;38(7):385-402.
16. von Kummer R, Allen KL, Holle R, et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 1997;205:327-33.
17. von Kummer R. Acute stroke: how to improve CT detection and avoid errors in radiology. Radiology 2000;216(3):920-23.
18. Hill MD, Barber PA, Demchuk AM, et al. Acute IV-IA revascularization therapy for severe ischemic stroke. Stroke 2002;33:279-82.
19. Caplan LR, Mohr JP, Kistler JP, et al. Clinical debate: should thrombolytic therapy be the first-line treatment for acute ischemic stroke? N Engl Med 1997;337:1309-13.
20. Derex L, Nighoghossian N, Hermier M, et al. Early detection of cerebral arterial occlusion on magnetic resonance angiography: predictive value of the baseline NIHSS score and impact on neurological outcome. Cerebrovosc Dis 2002;13:225-9.
21. Manelfe C, Larrue V, von Kummer R, et al. Association of hyperdense middle cerebral artery sign with clinical outcome in patients with tissue plasminogen activator. Stroke 1999;30:769-72.
22. Wolpert SM, Bruckmann H, Greenlee R, et al. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiology 1993;14:3-13.
23. Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989;25(4):382-90.
24. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273(18):1421-8.
25. Suwanwela NC, Phanthumchinda K, Suwanwela N. Transcranial Doppler sonography and CT angiography in patients with atherothrombotic middle cerebral artery stroke. AJNR Am J Neuroradiol 2002;23(8):1352-5.
26. Nederkoorn PJ, Elgersma OE, van der Graaf Y, et al. Carotid artery stenosis: accuracy of contrast-enhanced MR angiography for diagnosis. Radiology 2003;228(3):677-82.
27. Yang JJ, Hill MD, Morrish WF, et al. Comparison of pre- and pastcontrast 3D time-of-flight MR angiography for the evaluation of distal intracranial branch occlusions in acute ischemic stroke. AJNR Am J Neuroradiol 2002;23(4):557-67.
28. Hill MD, Rowley HA, Adler F, et al for the PROACT-II Investigators. Selection of acute ischaemic stroke patients for intra-arterial thrombolysis with prourokinase using ASPECTS. Stroke 2003;34:1925-31.
29. Von Kummer R, Weber J. Brain and vascular imaging in acute ischemic stroke: the potential of computed tomography. Neurology 1997;49(suppl 4):S52-5.
30. Ezzeddine MA, Lev MH, McDonald CT, et al. CT angiography with whole brain perfused blood volume imaging: added clinical value in the assessment of acute stroke. Stroke 2002;33:959-66.
31. Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA Stroke Study. Neurology 2000;55:1649-55.